Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $807.84bn | 76.68 | 0.55% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $353.97bn | 15.77 | 3.24% |
MRKMerck & Co | $330.96bn | 19.4 | 2.3% |
ABBVAbbvie | $299.17bn | 33.48 | 3.54% |
AMGNAmgen | $163.62bn | 43.32 | 2.83% |
PFEPfizer | $161.95bn | 10.19 | 5.77% |
CELG RTBristol-Myers Squibb Co | $84.08bn | 0.01 | 5760.6% |
BMYBristol-Myers Squibb Co | $84.08bn | 11.06 | 5.57% |
ZTSZoetis | $80.73bn | 33.77 | 0.88% |
GILDGilead Sciences | $80.61bn | 11.53 | 4.67% |
MCKMcKesson | $76.29bn | 26.15 | 0.4% |
BIIBBiogen | $32.82bn | 24.37 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $23.99bn | 18.63 | 2.03% |
RPRXRoyalty Pharma | $16.41bn | 15.4 | 2.95% |
BMRNBiomarin Pharmaceutical | $15.32bn | 76.46 | n/a |
INCYIncyte | $13.28bn | 17.53 | n/a |
VTRSViatris | $12.47bn | 20.96 | 4.58% |
CTLTCatalent | $10.21bn | n/a | n/a |